Home » Stocks » Illumina

Illumina, Inc. (ILMN)

Stock Price: $353.85 USD -1.82 (-0.51%)
Updated Aug 10, 2020 11:59 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 52.02B
Revenue (ttm) 3.35B
Net Income (ttm) 693.00M
Shares Out 147.00M
EPS (ttm) 4.68
PE Ratio 75.61
Forward PE 64.10
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 10, 2020
Last Price $353.85
Previous Close $355.66
Change ($) -1.82
Change (%) -0.51%
Day's Open 357.01
Day's Range 352.37 - 357.99
Day's Volume 389,464
52-Week Range 196.78 - 404.20

More Stats

Market Cap 52.02B
Enterprise Value 50.59B
Earnings Date (est) Oct 27, 2020
Ex-Dividend Date n/a
Shares Outstanding 147.00M
Float 145.42M
EPS (basic) 4.71
EPS (diluted) 4.68
FCF / Share 7.12
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.32%
FCF Yield 2.01%
Payout Ratio n/a
Shares Short 3.47M
Short Ratio 4.07
Short % of Float 2.57%
Beta 0.98
PE Ratio 75.61
Forward PE 64.10
P/FCF Ratio 49.73
PS Ratio 15.52
PB Ratio 12.12
Revenue 3.35B
Operating Income 861.00M
Net Income 693.00M
Free Cash Flow 1.05B
Net Cash 1.43B
Net Cash / Share 9.69
Gross Margin 74.63%
Operating Margin 25.69%
Profit Margin 20.70%
FCF Margin 31.21%
ROA 8.75%
ROE 15.58%
ROIC 17.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (18)

Buy 8
Overweight 0
Hold 6
Underweight 2
Sell 2

Analyst Consensus: Overweight

Price Target

$348.57*
(-1.49% downside)
Low
220
Current: $353.85
High
400
Target: 348.57
*Average 12-month price target from 14 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue3,5433,3332,7522,3982,2201,8611,4211,1491,056903
Revenue Growth6.3%21.11%14.76%8.02%19.27%30.97%23.74%8.81%16.93%-
Gross Profit2,4672,3001,8261,6661,5491,298912774709602
Operating Income985883606587613515134201199212
Net Income1,00282672646346235312515186.63125
Shares Outstanding147147146147145136125123123124
Earnings Per Share6.745.564.923.073.102.370.901.130.620.87
EPS Growth21.22%13.01%60.26%-0.97%30.8%163.33%-20.35%82.26%-28.74%-
Operating Cash Flow1,0511,142875779786501386292358273
Capital Expenditures-209-296-312-271-143-142-90.56-81.01-79.55-56.47
Free Cash Flow842846563508643359296211279216
Cash & Equivalents3,4143,5122,1451,5591,3861,3381,1661,3501,190894
Total Debt1,8361,9971,1921,0581,0911,291869842807312
Net Cash / Debt1,5781,51595350129647.34297508382583
Assets7,3166,9595,2574,2813,6883,3403,0192,5662,1961,839
Liabilities2,7033,1142,5082,0111,8391,8771,4861,2481,121641
Book Value4,6133,7582,7492,1971,8491,4631,5331,3191,0751,198
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Illumina, Inc.
Country United States
Employees 7,700
CEO Francis A. deSouza

Stock Information

Ticker Symbol ILMN
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: ILMN
IPO Date July 28, 2000

Description

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.